DKK1-Targeting Cholesterol-Modified siRNA Implication in Hair Growth Regulation

    Dimitri Papukashvili, Cong Liu, Nino Rcheulishvili, Fengfei Xie, Xinyun Wang, Shunping Feng, Xiaonan Sun, Chi Zhang, Yingyu Li, Yaohua He, Peng George Wang
    Image of study
    TLDR Blocking DKK1 with siRNA can improve hair growth.
    The study "DKK1-targeting cholesterol-modified siRNA implication in hair growth regulation" investigates the role of DKK1, an inhibitor of the Wnt/β-catenin signaling pathway, in hair growth. The researchers found that patients with androgenetic alopecia (AGA) had significantly higher concentrations of DKK1 in their scalp tissue. The study used small interfering RNA (siRNA) technology to target DKK1, with the siRNA sequence validated in vitro and in vivo through subcutaneous injections on mice. The results showed that DKK1-targeting siRNA significantly enhanced hair regeneration compared to the control group, suggesting that inhibiting DKK1 could be a critical factor in promoting hair growth and developing an effective treatment for AGA.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results

    Related Community Posts Join

    6 / 13 results

      community Has anyone used Magnesium L-Threonate ?

       74 upvotes 5 years ago
      Magnesium L-Threonate may help treat balding by reducing DKK-1 expression without affecting DHT. Users discuss its potential effectiveness and application methods, with some considering trying it topically.

      community Seb derm is eating my hair?!?!

      in Chat  41 upvotes 8 months ago
      A 22-year-old male is experiencing hair loss due to seborrheic dermatitis, not male pattern baldness, and is seeking advice. Suggestions include using Nizoral, sulfate-free and ketoconazole shampoos, cutting hair short, using cold water, avoiding picking scabs, and trying selenium sulfide shampoo or finasteride.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  40 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Similar Research

    5 / 537 results